This opportunity is no longer accepting applications.
grant NIH/NIAID 143

Development of Diagnostics for Mycoplasma genitalium Infection

This grant opportunity is seeking Fast-Track proposals for research related to Mycoplasma genitalium (Mg). The project does not accept Direct-to-Phase II proposals. The aim is to develop a diagnostic tool that combines detection of Mg and assessment of its antimicrobial susceptibilities, due to existing tests being slow and not commercially available. The grant anticipates awarding 1-2 project…

Fast-Track proposals will be accepted.\nDirect-to-Phase II proposals will not be accepted.\nNumber of anticipated awards: 1-2\nBudget (total costs):\nPhase I: Up to $300,000 for up to 1 year\nPhase II: Up to $1,500,000 for up to 3 years\nBackground\nMycoplasma genitalium (Mg) is a significant ca…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: August 2, 2024
Open for Submission: August 2, 2024
Application Window Closes: October 18, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.